CCC
STE icon

Crescent Capital Consulting’s Steris STE Stock Holding History

Crescent Capital Consulting’s Portfolio STE Stock Details STE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Hold
6
– – ﹤0.01% 506
2021
Q3 		$1K Hold
6
– – ﹤0.01% 551
2021
Q2 		$1K Hold
6
– – ﹤0.01% 481
2021
Q1 		$1K Hold
6
– – ﹤0.01% 482
2020
Q4 		$1K Buy
+6
New +$1.12K ﹤0.01% 453

Other funds holding STE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Crescent Capital Consulting's STE Position: Q4 2021 in Review

Crescent Capital Consulting held its Steris (STE) position steady in Q4 2021 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Crescent Capital Consulting first reported a position in STE in Q4 2020 and has held it in 5 quarters since. 650 funds tracked by Wall St. Rank hold STE as of Q4 2021.

  • Crescent Capital Consulting held 6 shares of Steris worth $1K as of Q4 2021.
  • Crescent Capital Consulting left its Steris share count unchanged in Q4 2021.
  • Steris made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #506 holding.
  • Crescent Capital Consulting first reported a position in Steris in Q4 2020 and has held it in 5 quarters since.
  • 650 funds tracked by Wall St. Rank held Steris as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.